Should Aspirin and PPIs Be Recommended for Patients With Barrett's Oesophagus?

The Lancet- United Kingdom

doi 10.1016/s0140-6736(18)31618-0

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

Elsevier BV

Related search

Letter: Should Barrett's Oesophagus Be Considered a Potential Cardiovascular Risk Factor?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Barrett's Oesophagus.

Postgraduate Medical Journal
Medicine
1998English

The Treatment of the Patients Presenting With Barrett's Oesophagus

Dokazatel'naya gastroenterologiya
2017English

Should All Diabetic Patients Be on Aspirin for Primary Prevention?

Expert Review of Cardiovascular Therapy
Internal MedicineMedicineCardiovascular MedicineCardiology
2019English

Assessment of Proliferation of Squamous, Barrett's and Gastric Mucosa in Patients With Columnar Lined Barrett's Oesophagus.

Gut
Gastroenterology
1992English

Aspirin Prevents NF-κB Activation and CDX2 Expression Stimulated by Acid and Bile Salts in Oesophageal Squamous Cells of Patients With Barrett's Oesophagus

Gut
Gastroenterology
2017English

Helicobacter Pylori Infection in Patients With Barrett's Oesophagus: A Prospective Immunohistochemical Study.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1996English

Risk of Malignant Progression in Patients With Barrett's Oesophagus: A Dutch Nationwide Cohort Study

Gut
Gastroenterology
2010English

GATA6 Expression in Barrett's Oesophagus and Oesophageal Adenocarcinoma

Digestive and Liver Disease
HepatologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy